Information Provided By:
Fly News Breaks for March 8, 2019
KIDS
Mar 8, 2019 | 08:23 EDT
BTIG analyst Ryan Zimmerman raised his price target on OrthoPediatrics to $44 and kept his Buy rating after the company's "encouraging" results in Q4. The analyst believes that its initiated FY19 revenue growth outlook of 21%-23% is conservative given the management's "instrument set investment and current demand rates for KIDS products". Zimmerman sees OrthoPediatrics results bolstered in FY19 by the company's "combination of new products, distributor headcount growth, and the impact of instrument sets bought in FY18".
News For KIDS From the Last 2 Days
There are no results for your query KIDS
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.